ORBIMED ADVISORS LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is a Director in AMARIN CORP PLC\UK ($AMRN) and a 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and a 10% Owner in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in Anthera Pharmaceuticals Inc ($ANTH) and a 10% Owner in COMPLETE GENOMICS INC ($GNOM) and a 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX) and a 10% Owner in Relypsa Inc ($RLYP) and a 10% Owner in Mirati Therapeutics, Inc. ($MYG).
Address: 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK 10022 NY
Companies in which ORBIMED ADVISORS LLC is an Insider
AMARIN CORP PLC\UK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 5,700 shares
Current Value: $18,924
Latest Transaction: Sep 05 2012
$AMRN Market Capitalization: $901.76M
$AMRN Previous Close: $3.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMBIT BIOSCIENCES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 14,067 shares
Latest Transaction: May 24 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 7,462,000 shares
Current Value: $4,402,580
Latest Transaction: Feb 01 2013
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
COMPLETE GENOMICS INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 27,859 shares
Latest Transaction: Jul 13 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director, 10% Owner
Holdings: 1,485,324 shares
Current Value: $168,688,247
Latest Transaction: Aug 27 2014
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,267,000 shares
Latest Transaction: Feb 05 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 2,446,000 shares
Current Value: $102,120,500
Latest Transaction: Mar 13 2012
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 9,941,551 shares
Latest Transaction: Nov 20 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
Sentiment: All, AMRN, AMBI, ANTH, GNOM, ICPT, MYG, PCRX, RLYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2015 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 20.00 | 100,000 | 2,000,000 | 1,267,000 | 1.2 M to 1.3 M (+8.57 %) |
| Jul 01 2014 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 20.04 | 5,000 | 100,200 | 1,167,000 | 1.2 M to 1.2 M (-0.43 %) |
| Jul 01 2014 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 21.11 | 4,717 | 99,576 | 1,172,000 | 1.2 M to 1.2 M (-0.40 %) |
| Jul 01 2014 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 20.33 | 9,283 | 188,723 | 1,176,717 | 1.2 M to 1.2 M (-0.78 %) |
| Jul 01 2014 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.09 | 9,212 | 212,705 | 1,186,000 | 1.2 M to 1.2 M (-0.77 %) |
| Jul 01 2014 | MYG | Mirati Therapeutic ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 21.79 | 79,120 | 1,724,025 | 1,195,212 | 1.3 M to 1.2 M (-6.21 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 302.34 | 400 | 120,936 | 1,485,324 | 1.5 M to 1.5 M (-0.03 %) |